According to Genomma Lab Internacional's latest financial reports the company's current earnings are NZ$0.97 Billion. In 2023 the company made an earning of NZ$0.17 Billion a decrease over its 2022 earnings that were of NZ$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | NZ$0.21 B | 20.98% |
2023 | NZ$0.17 B | -14.5% |
2022 | NZ$0.20 B | 5.48% |
2021 | NZ$0.19 B | 8.95% |
2020 | NZ$0.17 B | 23.73% |
2019 | NZ$0.14 B | -10.8% |
2018 | NZ$0.16 B | -21.37% |
2017 | NZ$0.20 B | -243.43% |
2016 | -NZ$0.15 Billion | 1.87% |
2015 | -NZ$0.15 Billion | -150.99% |
2014 | NZ$0.27 B | -22.77% |
2013 | NZ$0.35 B | 11.65% |
2012 | NZ$0.32 B | 17.84% |
2011 | NZ$0.27 B | 21.36% |
2010 | NZ$0.22 B | 55.45% |
2009 | NZ$0.14 B |